BENTSUR RON (Chairman & CEO) purchased 0.6% of their position (20K shares) of NUVECTIS PHARMA, INC. on the open market
Open‑market purchase worth $98.4K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/18/2024ACC: 0001104659-24-119976
DirectorOfficer· Chairman & CEO
Since Feb 2022
+20K
Net shares
Net buyer
$98.4K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
20K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+20K
Price / share
$4.92
Trade value
$98.40K
% of position
0.6%
11/15/2024
3.25M→3.27M
Total
Net shares
+20K
Net value
$98.40K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/15/2024 | P · Purchase | +20K | $4.92 | $98.40K | 0.6% | 3.25M | 3.27M |
| Total | +20K | $98.40K | ||||||
Derivative Transactions0
No derivative transactions reported